JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
IES Holdings
IESC
$15.3B
| $319K | ﹤0.01% |
12,455
-330
| -3% | -$7.14K |
|
|
BWIN
4302
Baldwin Insurance Group
BWIN
$3B
| $319K | ﹤0.01% |
+19,846
| New | +$317K |
|
4303
Village Super Market
VLGEA
$627M
| $318K | ﹤0.01% |
13,727
+895
| +7% | +$23.2K |
|
|
TGA
4304
DELISTED
Transglobe Energy Corp
TGA
| $317K | ﹤0.01% |
229,902
-92,098
| -29% | -$115K |
|
|
PWOD
4305
DELISTED
Penns Woods Bancorp
PWOD
| $316K | ﹤0.01% |
8,906
+6,657
| +296% | +$212K |
|
4306
Saga Communications
SGA
$64.6M
| $314K | ﹤0.01% |
10,322
+3,363
| +48% | +$102K |
|
|
KZR
4307
DELISTED
Kezar Life Sciences
KZR
| $313K | ﹤0.01% |
7,817
+2,492
| +47% | +$76.7K |
|
4308
First Trust Water ETF
FIW
$1.92B
| $312K | ﹤0.01% |
5,200
| – | – |
|
|
ATXS
4309
DELISTED
Astria Therapeutics
ATXS
| $310K | ﹤0.01% |
8,748
+3,396
| +63% | +$107K |
|
4310
MVB Financial
MVBF
$397M
| $310K | ﹤0.01% |
12,440
+9,346
| +302% | +$198K |
|
4311
Alliance Resource Partners
ARLP
$3.23B
| $309K | ﹤0.01% |
28,529
+13,467
| +89% | +$162K |
|
4312
AXT Inc
AXTI
$5.13B
| $309K | ﹤0.01% |
71,097
+58,471
| +463% | +$188K |
|
4313
Turning Point Brands
TPB
$1.73B
| $309K | ﹤0.01% |
10,795
+8,082
| +298% | +$203K |
|
4314
Vanguard Russell 1000 ETF
VONE
$8.68B
| $309K | ﹤0.01% |
2,096
| – | – |
|
4315
iShares Global 100 ETF
IOO
$9.43B
| $308K | ﹤0.01% |
5,708
| – | – |
|
4316
iShares New York Muni Bond ETF
NYF
$1.41B
| $308K | ﹤0.01% |
5,396
| – | – |
|
4317
United Natural Foods
UNFI
$2.9B
| $308K | ﹤0.01% |
35,152
-2,771
| -7% | -$22.3K |
|
|
TRHC
4318
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $308K | ﹤0.01% |
6,335
-7,348
| -54% | -$344K |
|
4319
Galmed Pharmaceuticals
GLMD
$4.63M
| $307K | ﹤0.01% |
295
-47
| -14% | -$40.4K |
|
4320
Norwood Financial Corp
NWFL
$376M
| $307K | ﹤0.01% |
7,887
+5,995
| +317% | +$205K |
|
4321
RPC Inc
RES
$1.4B
| $307K | ﹤0.01% |
58,597
-1,995,833
| -97% | -$8.95M |
|
4322
RGC Resources
RGCO
$225M
| $307K | ﹤0.01% |
10,757
+8,292
| +336% | +$240K |
|
4323
Tecnoglass Holdings Inc.
TGLS
$1.86B
| $307K | ﹤0.01% |
37,189
+19,118
| +106% | +$154K |
|
4324
Coastal Financial
CCB
$754M
| $306K | ﹤0.01% |
18,605
+10,350
| +125% | +$167K |
|
4325
PUT
Targa Resources
TRGP
$57.6B
| $306K | ﹤0.01% |
7,500
| – | – |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.